Autoimmunity and Inflammation Model Construction Service

Autoimmunity and Inflammation Model Construction Service

Dedicated to Discovery: Glycobiology Autoimmunity and Inflammation Model Construction Service

Glycosylation plays an important role in the development of certain diseases. At CD BioGlyco, we provide comprehensive and professional Glycobiology Disease Model Development Services. Glycobiology Disease Model Construction is one of the core technologies of this development service.

Autoimmunity and inflammation are closely related to glycosylation and its model construction is an important step in studying diseases and glycosylation processes. There are many diseases related to autoimmunity and inflammation. Our autoimmunity and inflammation model construction services include but are not limited to rheumatoid arthritis model construction service, inflammatory bowel disease model construction service, systemic lupus erythematosus model construction service, Tn syndrome model construction service, diabetes mellitus model construction service, etc.

Schematic diagram of autoimmunity and inflammation model construction.

  • Construction of mouse animal model
    • Gene knockout mouse model
      We use gene editing technologies such as CRISPR-Cas9 to precisely knock out specific genes related to glycosylation in mice, such as glycosyltransferases and glycosidases. These models simulate abnormal glycosylation in humans due to genetic defects and then study the mechanism of glycosylation in autoimmune and inflammatory diseases.
    • Conditional gene knockout mouse model
      To more accurately model the spatiotemporal specificity of disease development, we construct conditional knockout mouse models. Through tissue-specific promoters, we knock out glycosylation-related genes at specific time points and tissues and organs, thereby in-depth studying the pathological effects of abnormal glycosylation in different tissues.
    • Transgenic mouse model
      We introduce foreign genes into the mouse genome through transgenic technology to over-express or under-express specific glycosylases. These models help us study the impact of changes in glycosylation levels on physiological and pathological processes in mice, and provide new ideas for disease treatment.
  • Model verification and optimization
    • Biological verification
      After the model is constructed, we verify the accuracy of the model through a series of biological experiments. These experiments include detecting changes in glycosylation levels, observing tissue pathological changes, detecting relevant biomarkers, etc. Through these experiments, we ensure that we build models that accurately mimic the role of glycosylation abnormalities in autoimmune and inflammatory diseases.
    • Model optimization
      Based on experimental results and customer feedback, we continue to optimize the model construction plan. This may include adjusting gene knockout/knockdown levels, optimizing experimental conditions, etc.

Assays Available

  • PK/PD blood analysis
  • Histopathological evaluation
  • Biomarker analysis
  • Cytokine/chemokine analysis
  • Immunohistochemistry
  • Flow cytometry in lymph nodes or spleen

Publication Data

Technology: The research of autoimmune pathology

Journal: Frontiers in Immunology

IF: 9.4

Published: 2018

Results: The authors investigated if sialylated autoantigen-reactive IgG Abs could mitigate autoimmune pathology in various mouse models. It was discovered that sialylated IgG auto-Abs did not provoke inflammation and lupus nephritis in a B cell receptor (BCR) transgenic lupus model, but were linked with reduced occurrences of pathogenic Th1, Th17, and B cell reactions. Consistent with these findings, it was observed that the transference of minimal immune complexes containing sialylated IgG Abs successfully dampened the progression of nephritis.

Fig.1 Sialylated Col II-reactive monoclonal IgG Abs suppress collagen-induced arthritis.Fig.1 Sialylated collagen type II-reactive monoclonal IgG Abs suppress collagen-induced arthritis. (Bartsch, et al., 2018)

Applications

  • Glycosylation autoimmunity and inflammation models help researchers further study how glycosylation affects immune responses and inflammatory pathways, thereby revealing the pathogenesis of specific diseases.
  • Glycosylation-modified proteins or cell surface receptors may become potential targets for drug action. Model construction can help identify these targets and facilitate the development of drugs targeting specific glycosylation processes to modulate immune responses and inflammation.
  • The constructed model can be used to evaluate the efficacy and safety of drugs. The effects of drugs on the body can be predicted and provide important guidance for drug development by simulating the impact of drugs on the glycosylation process.

Frequently Asked Questions

  • Why choose your autoimmunity and inflammation model construction services?

Our services focus on the field of glycobiology and have extensive experience and expertise to provide clients with high-quality model construction services. We use advanced gene editing technology and rigorous experimental procedures to ensure that the models we build accurately simulate the role of abnormal glycosylation in autoimmune and inflammatory diseases. We also provide personalized customization services and tailor-made exclusive models according to meet different research needs.

  • Does your model construction service include subsequent experimental validation?

Yes, our model construction services include subsequent experimental validation. After the model is built, we conduct a series of biological experiments to verify the accuracy and reliability of the model. These experiments may include detection of glycosylation levels, histopathological analysis, determination of relevant biomarkers, etc. Through these experimental verifications, we ensure that the models provided truly reflect the role of abnormal glycosylation in autoimmune and inflammatory diseases, providing strong support for clients.

At CD BioGlyco, we are experts in providing autoimmunity and inflammation model construction services related to glycosylation. This specialization makes us an innovator in our field, utilizing cutting-edge technologies and methods. Please feel free to contact us if you are interested in our autoimmunity and inflammation model construction service.

Reference

  1. Bartsch, Y.C.; et al. Sialylated autoantigen-reactive IgG antibodies attenuate disease development in autoimmune mouse models of lupus nephritis and rheumatoid arthritis. Frontiers in Immunology. 2018, 9: 1183.
This service is for Research Use Only, not intended for any clinical use.

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0